Detalhe da pesquisa
1.
Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey.
Lancet Reg Health Am
; 11: None, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35865654